Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,850 | -9,121 | -5,737 | -2,726 | -11,122 |
| Depreciation Amortization | 1 | 1 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 569 | 400 | 642 | 144 | -16 |
| Other Working Capital | -112 | -416 | -380 | 488 | 605 |
| Other Operating Activity | 147 | 139 | 81 | 45 | 2,469 |
| Operating Cash Flow | $-11,245 | $-8,997 | $-5,395 | $-2,049 | $-8,063 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -3 |
| Other Investing Activity | -3 | -3 | 0 | 0 | 0 |
| Investing Cash Flow | $-3 | $-3 | $N/A | $N/A | $-3 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,763 | 7,214 | 6,282 | 6,282 | 6,322 |
| Other Financing Activity | -30 | -28 | -23 | -19 | -53 |
| Financing Cash Flow | $7,733 | $7,186 | $6,260 | $6,263 | $6,269 |
| Beginning Cash Position | 4,706 | 4,706 | 4,706 | 4,706 | 6,504 |
| End Cash Position | 1,191 | 2,892 | 5,571 | 8,920 | 4,706 |
| Net Cash Flow | $-3,515 | $-1,815 | $865 | $4,214 | $-1,797 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,245 | -8,997 | -5,395 | -2,049 | -8,063 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -3 |
| Free Cash Flow | -11,245 | -8,997 | -5,395 | -2,049 | -8,066 |